Ignite Creation Date:
2024-05-06 @ 3:31 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652700
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2020-12-02
Brief Title:
Oral Islatravir MK-8591 Once-Monthly as Preexposure Prophylaxis PrEP in Men and Transgender Women Who Are at High Risk for HIV-1 Infection MK-8591-024
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC